ImmunoGen, Inc. (NASDAQ:IMGN) gained 4.16% in yesterday’s session, going up from its prior closing price of $6.01 to $6.26. The price has fallen in 5 of the last 10 days, but is still up by 7.56% during the last two weeks. Trading activity decreased by -0.18 million shares, and in total, 1.22 M shares exchanged hands for about $7.67 million. It should be noted that increasing price and decreasing volume show lack of interest and this is a warning that something has fundamentally changed.
Inside IMGN’s Recent Trend
ImmunoGen, Inc. (IMGN) enjoys staying at the middle end of a sharp increasing trend in a short period of time and issued considerable signs about additional rally. Short-term traders are predicted to see a rally of 20.16% over the course of a quarter and, with 90% chance the price will be floating in the range of $6.56 and $10.13 in this timeframe.
ImmunoGen, Inc. Technical Signals
IMGN is a buy based on short-term MA; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On additional rally, the share price will meet long term resistance at around $6.27. On a drop, the stock is likely to find some support over the short run, which begins at $6.03. A buy signal will be generated if it crosses above the long term moving average. Meanwhile, a price down versus the short-term MA will be a fresh sales call.
ImmunoGen, Inc. (NASDAQ:IMGN) Support And Resistance Levels
ImmunoGen, Inc. (IMGN) recorded volume accumulation so there will probably be a surplus of buyers at $6.02. In case of gains, the next resistance from accumulated volume will be at $6.82, $6.96 and $7.48.
ImmunoGen, Inc. (IMGN) Risk Assessment
A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $0.25 between high and low, or 4.15%. The average volatility for the past week stood at 6.18%.